134 related articles for article (PubMed ID: 1943746)
21. Mullerian inhibiting substance requires its N-terminal domain for maintenance of biological activity, a novel finding within the transforming growth factor-beta superfamily.
Wilson CA; di Clemente N; Ehrenfels C; Pepinsky RB; Josso N; Vigier B; Cate RL
Mol Endocrinol; 1993 Feb; 7(2):247-57. PubMed ID: 8469238
[TBL] [Abstract][Full Text] [Related]
22. Mullerian Inhibiting Substance enhances subclinical doses of chemotherapeutic agents to inhibit human and mouse ovarian cancer.
Pieretti-Vanmarcke R; Donahoe PK; Pearsall LA; Dinulescu DM; Connolly DC; Halpern EF; Seiden MV; MacLaughlin DT
Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17426-31. PubMed ID: 17088539
[TBL] [Abstract][Full Text] [Related]
23. Müllerian inhibiting substance blocks the protein kinase A-induced expression of cytochrome p450 17alpha-hydroxylase/C(17-20) lyase mRNA in a mouse Leydig cell line independent of cAMP responsive element binding protein phosphorylation.
Laurich VM; Trbovich AM; O'Neill FH; Houk CP; Sluss PM; Payne AH; Donahoe PK; Teixeira J
Endocrinology; 2002 Sep; 143(9):3351-60. PubMed ID: 12193547
[TBL] [Abstract][Full Text] [Related]
24. Insensitivity of the chick embryo müllerian duct to human recombinant müllerian-inhibiting substance.
Weniger JP; Cate RL; Zeis A
J Mol Endocrinol; 1992 Feb; 8(1):73-7. PubMed ID: 1543536
[TBL] [Abstract][Full Text] [Related]
25. Human recombinant mullerian inhibiting substance inhibits epidermal growth factor.
Coughlin JP; Cigarroa F; Donahoe PK; McLaughlin DT
Curr Surg; 1988; 45(3):204-5. PubMed ID: 3402255
[No Abstract] [Full Text] [Related]
26. Müllerian inhibiting substance inhibits testosterone synthesis in adult rats.
Sriraman V; Niu E; Matias JR; Donahoe PK; MacLaughlin DT; Hardy MP; Lee MM
J Androl; 2001; 22(5):750-8. PubMed ID: 11545286
[TBL] [Abstract][Full Text] [Related]
27. Müllerian inhibiting substance signaling uses a bone morphogenetic protein (BMP)-like pathway mediated by ALK2 and induces SMAD6 expression.
Clarke TR; Hoshiya Y; Yi SE; Liu X; Lyons KM; Donahoe PK
Mol Endocrinol; 2001 Jun; 15(6):946-59. PubMed ID: 11376113
[TBL] [Abstract][Full Text] [Related]
28. Human müllerian inhibiting substance: enhanced purification imparts biochemical stability and restores antiproliferative effects.
Ragin RC; Donahoe PK; Kenneally MK; Ahmad MF; MacLaughlin DT
Protein Expr Purif; 1992 Jun; 3(3):236-45. PubMed ID: 1392620
[TBL] [Abstract][Full Text] [Related]
29. Müllerian inhibiting substance in reproduction and cancer.
Donahoe PK
Mol Reprod Dev; 1992 Jun; 32(2):168-72. PubMed ID: 1637555
[TBL] [Abstract][Full Text] [Related]
30. The role of insulin 3, testosterone, Müllerian inhibiting substance and relaxin in rat gubernacular growth.
Kubota Y; Temelcos C; Bathgate RA; Smith KJ; Scott D; Zhao C; Hutson JM
Mol Hum Reprod; 2002 Oct; 8(10):900-5. PubMed ID: 12356938
[TBL] [Abstract][Full Text] [Related]
31. Androgen stimulation of nucleotide pyrophosphatase during mullerian duct regression.
Fallat ME; Hutson JM; Budzik GP; Donahoe PK
Endocrinology; 1984 May; 114(5):1592-8. PubMed ID: 6143657
[TBL] [Abstract][Full Text] [Related]
32. Müllerian inhibitory substance induces growth of rat preantral ovarian follicles.
McGee EA; Smith R; Spears N; Nachtigal MW; Ingraham H; Hsueh AJ
Biol Reprod; 2001 Jan; 64(1):293-8. PubMed ID: 11133686
[TBL] [Abstract][Full Text] [Related]
33. Müllerian-inhibiting substance regulates androgen synthesis at the transcriptional level.
Teixeira J; Fynn-Thompson E; Payne AH; Donahoe PK
Endocrinology; 1999 Oct; 140(10):4732-8. PubMed ID: 10499532
[TBL] [Abstract][Full Text] [Related]
34. Mullerian inhibiting substance: a fetal hormone with surgical implications.
Hutson JM; Donahoe PK; Budzik GP
Aust N Z J Surg; 1985 Dec; 55(6):599-605. PubMed ID: 2870703
[TBL] [Abstract][Full Text] [Related]
35. Müllerian inhibiting substance in sex-reversed dogs.
Meyers-Wallen VN; Donahoe PK; Manganaro T; Patterson DF
Biol Reprod; 1987 Nov; 37(4):1015-22. PubMed ID: 3689844
[TBL] [Abstract][Full Text] [Related]
36. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells.
Lee MM; Seah CC; Masiakos PT; Sottas CM; Preffer FI; Donahoe PK; Maclaughlin DT; Hardy MP
Endocrinology; 1999 Jun; 140(6):2819-27. PubMed ID: 10342873
[TBL] [Abstract][Full Text] [Related]
37. Localization of Mullerian inhibiting substance receptors in various human cancer cell lines.
Rodina AV; Gukasova NV; Makarov VA; Kondrasheva IG; Khomyakova AV; Posypanova GA; Popova ON; Moskaleva EY; Severin SE
Biochemistry (Mosc); 2008 Jul; 73(7):797-805. PubMed ID: 18707588
[TBL] [Abstract][Full Text] [Related]
38. Thyroid hormone and follicle-stimulating hormone regulate Müllerian-inhibiting substance messenger ribonucleic acid expression in cultured neonatal rat Sertoli cells.
Arambepola NK; Bunick D; Cooke PS
Endocrinology; 1998 Nov; 139(11):4489-95. PubMed ID: 9794457
[TBL] [Abstract][Full Text] [Related]
39. Müllerian inhibiting substance is present in testes of dogs with persistent müllerian duct syndrome.
Meyers-Wallen VN; Donahoe PK; Ueno S; Manganaro TF; Patterson DF
Biol Reprod; 1989 Nov; 41(5):881-8. PubMed ID: 2576223
[TBL] [Abstract][Full Text] [Related]
40. The müllerian inhibitor and mammalian sexual development.
Behringer RR
Philos Trans R Soc Lond B Biol Sci; 1995 Nov; 350(1333):285-8; discussion 289. PubMed ID: 8570693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
